EAN Research Paper for February 2026: Fremanezumab in Children and Adolescents with Episodic Migraine. Migraine is a common neurological disorder in childhood and adolescence, with an estimated overall prevalence of 11%. Fremanezumab is a humanised monoclonal antibody that selectively targets calcitonin gene–related peptide (CGRP) and has been shown to reduce […]
Research Paper of the Month: Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease. This study assessed cognitively unimpaired older adults using pedometer-measured physical activity, longitudinal Aβ and tau PET imaging, and annual cognitive evaluations over 14 years. Read more. IICN members are Associate Members of EAN and enjoy […]
Research Paper of the Month: A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus. Idiopathic normal-pressure hydrocephalus (iNPH) is a neurological disorder characterised by impairment in gait, cognition and bladder control in older adults. Although cerebrospinal fluid (CSF) shunting has long been used as a treatment, its clinical effectiveness remains […]
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease) – Isabella Colonna
Applications are invited for submission from members of the IICN for a Fellowship Research Grant in Clinical Neuroscience. Aim The aim of this grant is to support research in the clinical neurosciences. The grant recipient will be required to make a short presentation of their project to a meeting of […]
